QC
MXCT icon

Quadrature Capital’s MaxCyte MXCT Stock Holding History

Quadrature Capital’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130K Buy
+105,516
New +$105K ﹤0.01% 1439
2026
Q1 		– Sell
-36,348
Closed -$56.3K – 1689
2025
Q4 		$56.3K Sell
36,348
-7,769
-18% -$12.4K ﹤0.01% 1165
2025
Q3 		$70.1K Buy
44,117
+16,357
+59% +$28.4K ﹤0.01% 928
2025
Q2 		$60.4K Buy
+27,760
New +$67.2K ﹤0.01% 932
2025
Q1 		– Sell
-10,249
Closed -$42.8K – 1340
2024
Q4 		$42.8K Buy
+10,249
New +$38.7K ﹤0.01% 965

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Quadrature Capital's MXCT Position: Q2 2026 in Review

Quadrature Capital opened a new position in MaxCyte (MXCT) in Q2 2026: 105,516 shares worth $130K. The stake represents ﹤0.01% of the portfolio and ranks #1439 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in MXCT as recently as Q4 2025.

Quadrature Capital first reported a position in MXCT in Q4 2024 and has held it in 5 quarters since. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Quadrature Capital held 105,516 shares of MaxCyte worth $130K as of Q2 2026.
  • MaxCyte was a new Quadrature Capital position in Q2 2026.
  • MaxCyte made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1439 holding.
  • Quadrature Capital first reported a position in MaxCyte in Q4 2024 and has held it in 5 quarters since.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.